Oncolytic Virus Therapy Market is estimated to grow at a 24.5% CAGR during the forecast period for 2025-2034. In recent decades, the healthcare burden of Cancer increasing rapidly with an increasing incidence rate. The massive investment in resear...
Global Capsule Endoscopy Market Size is valued at USD 557.1 Million in 2024 and is predicted to reach USD 1330.9 Million by the year 2034 at a 9.2% CAGR during the forecast period for 2025-2034. Capsule endoscopy makes use of a tiny wireless camer...
Global Alternative Proteins Market Size is valued at USD 16.9 Bn in 2024 and is predicted to reach USD 53.2 Bn by the year 2034 at a 12.2 % CAGR during the forecast period for 2025-2034. The Alternative proteins are food-technology or plant-based al...
The Allogeneic Cell Therapy Market Size is valued at 997.36 Million in 2022 and is predicted to reach 2853.34 Million by the year 2031 at a 12.7 % CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: ...
Global Immuno-Oncology Cell Therapy Market Size is valued at USD 11.9 Billion in 2024 and is predicted to reach USD 95.3 Billion by the year 2034 at a 23.2% CAGR during the forecast period for 2025-2034. Immuno-oncology cell therapies are a remark...
Global AI-Based Clinical Trial Solution Providers Market Size is valued at USD 2.3 Billion in 2024 and is predicted to reach USD 16.6 Billion by the year 2034 at a 22.0% CAGR during the forecast period for 2025-2034. Artificial Intelligence is a s...
Rituximab Biosimilar Market is expected to grow at a 12.3% CAGR during the forecast period for 2025-2034. Rituximab is a chimeric anti-CD20 antibody that binds to the CD20 antigen present on the standard and malignant B cells surface. It is indica...
Trastuzumab Biosimilar Market is expected to grow at a 25.0 % CAGR during the forecast period for 2025-2034. Trastuzumab is a recombinant DNA-derived humanized monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2). HER2...
The nerve growth factor is a tumor tissue produced growth factor that promotes the growth and differentiation of sympathetic and sensory ganglia. It is the first growth factor to be identified. An elevated level of nerve growth factor leads to inflam...
The Cancer Biosimilars Market is expected to grow at a 20.0 % CAGR during the forecast period for 2023-2031. Biosimilar is defined as a type of biological product that is approved by respective regulatory bodies because of its clinical simil...
Pharmaceuticals